Unipharma

What Unipharma does

Unipharma (Universal Pharmaceutical Industries / الشركة العالمية للصناعات الدوائية) is a Damascus-based pharmaceutical manufacturer founded in 1994 and operating under the Maatouk Group conglomerate alongside Maatouk Pharma and Maatouk Drags Store. The company produces a broad portfolio of branded and licensed generic pharmaceutical products spanning cardiovascular (Tensocard, KASPRO, ARNI, Ramp, Uni Lasix, Torespot, Tensocard Plus, Ramp Plus, Altiazem RR, Cardizem, Uni Nebilet), neurological and anticonvulsant (Ralvic Chrono, VETRA, Dicloneur, Dovein), NSAIDs and analgesics (Toricox, Feldexam, Uni Brufen, Mepstan, Sportgel, Fastum Gel), respiratory (Asmalair, Rinoless, Clarinase), dermatological (Clotriderm, Quadriderm-UNI), urology (Admira), vitamins and minerals (B-PLUS, UniViforcit Zn), and other categories. The portfolio combines in-house branded formulations with products licensed from major international pharmaceutical companies including Pfizer, Sanofi, Bristol-Myers Squibb, Abbott, Merck, Menarini Group, Solvay, Vifor, Pierre Faber, Schering-Plough, Hikma, and Orion Corporation.

The business model is a B2B2C prescription and OTC pharmaceutical sales operation. Unipharma manufactures finished dosage forms (tablets, capsules, effervescents, topical gels, nasal sprays, suspensions) and distributes them through licensed pharmacies and healthcare providers across Syria. Manufacturing is conducted under ISO 9001, ISO 14001, and ISO 45001 certifications. Go-to-market relies on pharmacy-channel distribution, medical conferences (DAMFAD), community health awareness campaigns (World Diabetes Day, World Heart Day across Damascus, Sweida, and other cities), and a corporate website with newsletter subscription. Pricing is not publicly disclosed and products are sold against physician prescriptions through the Syrian pharmacy supply chain.

Unipharma is a private, family-controlled manufacturer with 51-100 employees, headquartered in Damascus, Syria. Operations are single-country with no disclosed international footprint, no external funding rounds, no M&A activity, and no public listing. The company is part of the vertically integrated Maatouk Group, which spans pharmaceutical manufacturing (Maatouk Pharma), retail pharmacy (Maatouk Drags Store), and contract manufacturing (Unipharma). Revenue, ownership percentages, and management team composition are not publicly disclosed.

Name

Unipharma

Legal name

Universal Pharmaceutical Industries (Unipharma) - الشركة العالمية للصناعات الدوائية (يونيفارما)

Website

https://unipharma-sy.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Unipharma is a Damascus-based, Maatouk Group-affiliated pharmaceutical manufacturer founded in 1994 that produces branded and licensed generic drugs across cardiovascular, neurological, dermatological, respiratory, and vitamin categories for distribution through Syrian pharmacies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIAAAA

Primary Care & General Medicine Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIAAAE

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIAAAK

Dermatology & Aesthetics Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Cardiovascular drugs
• NSAIDs analgesics
• Dermatological drugs

Headquarters

HQ city

Damascus

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical product sales: Manufacturing and selling branded pharmaceutical products across multiple therapeutic categories including cardiovascular, neurological, musculoskeletal, respiratory, dermatological, and anti-infective medications. Products are distributed through pharmacies and healthcare providers in Syria.

Distribution channels1 record

Marketing channels3 records

Core offering

Unipharma manufactures and distributes branded and generic pharmaceutical products across multiple therapeutic categories including cardiovascular, neurological, dermatological, respiratory, anti-infective, NSAIDs, and vitamins/minerals in Syria. Products are formulated locally under licensing arrangements with international pharmaceutical companies and distributed through licensed pharmacies to patients via physician prescriptions.

Product overview

Unipharma is a Syrian pharmaceutical company manufacturing a comprehensive portfolio of generic and branded pharmaceutical products across multiple therapeutic categories. The product portfolio includes cardiovascular drugs (antihypertensives like Tensocard, Ramp, Nebilet; diuretics like Lasix, Torespot; cardiac medications like ARNI), neurological and psychiatric drugs (anticonvulsants like Ralvic Chrono, VETRA, Finlepsin; antidepressants like Faverin, Setoxin), NSAIDs and analgesics (Toricox, Feldexam, Fastum Gel, Sportgel), respiratory drugs (Asmalair for asthma; nasal sprays like Rineless), antihistamines (Clarityn, Aerius, Polaramine), vitamins and minerals (B-PLUS, Kalsifor), dermatological products (Clotriderm, Quadriderm-UNI), and muscle relaxants (Zomoland). The company operates under the Maatouk Group umbrella and holds multiple ISO certifications for quality, environmental, and occupational health and safety management systems.

Differentiator

Problem solved

Functional benefit

Products and services

• DOVEIN

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Maatouk GroupcoreStrategic or Co-development PartnerParent company and corporate group. Maatouk Group includes Maatouk Pharma and Maatouk Drags Store. Strategic partnership for pharmaceutical manufacturing and distribution in Syria.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Pfizer: Global pharmaceutical leader and named Unipharma licensing partner; comparable as the upstream innovator whose formulations Unipharma manufactures/distributes locally in Syria.
• Hikma Pharmaceuticals: MENA-headquartered generic and specialty pharmaceutical manufacturer operating across the same therapeutic categories as Unipharma; Hikma is already named as a Unipharma licensing partner, making it the most direct regional comparable.
• Sanofi: Global pharmaceutical major and one of Unipharma's named licensors; operates broadly in the same cardiovascular, neurology, dermatology, and respiratory categories Unipharma distributes in the Syrian market.
• Menarini Group: Italian pharmaceutical group and a named Unipharma licensor; comparable through its broad cardiovascular, dermatology, and respiratory product lines that overlap directly with Unipharma's catalogue.
• AWD Germed (Stada): German generic manufacturer (now part of Stada) and named Unipharma licensing partner; comparable as a licensor whose cardiovascular and dermatology products underpin portions of Unipharma's portfolio.

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based generic pharmaceutical manufacturer serving MENA markets; comparable to Unipharma through local manufacturing, multi-therapeutic portfolio (cardiovascular, CNS, dermatology), and reliance on licensing and in-licensing partnerships.
• SPIMACO Addwaeih: Leading Saudi generic pharmaceutical manufacturer with regional distribution; operates a comparable licensed-generic and branded-generic model across cardiovascular, CNS, and respiratory categories that overlap with Unipharma's catalogue.
• EIPICO: Egyptian pharmaceutical manufacturer producing generic finished dosage forms across multiple therapeutic categories; comparable to Unipharma in business model (generic manufacturing for regional markets) and therapeutic breadth.
• Tabuk Pharmaceuticals: Saudi Arabia-based generic pharmaceutical manufacturer with a broad multi-therapeutic portfolio including cardiovascular, CNS, and dermatology products; serves the same Middle East patient base with a similar generic-focused manufacturing model.
• Pharco Pharmaceuticals: Egypt's largest generic pharmaceutical manufacturer with a broad therapeutic portfolio and licensing relationships with global pharma — directly comparable as an MENA manufacturer-distributor for generics across cardiovascular, neurology, and dermatology.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/maatouk-group

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unipharma